Synergistic anti-Pneumocystis carinii effects erythromycin sulfisoxazole Pneumocystis pneumonitis immunosuppressed rats administration mg erythromycin mg/kg/day sulfisoxazole untreated control erythromycin-treated animals infection rats sulfisoxazole pneumonitis similar pattern response drugs rats carinii pneumonitis erythromycin sulfisoxazole ratio effective several dose combinations safety record decades clinical use drug combination broad spectrum coverage causes diffuse pneumonitis Chlamydia Mycoplasma Legionella study erythromycin-sulfisoxazole AIDS patients 